How to get a headstart with clinical evidence requirements for new EU IVD Reg
This article was originally published in Clinica
Executive Summary
Clinical evidence requirements are among the new rules that are going to have the biggest impact on the IVD industry once the forthcoming EU IVD Regulation eventually takes effect. IVD manufacturers would do well to make use of the transition period before the new Regulation takes full effect – this is likely to happen around the end of this decade – and start gathering and documenting their evidence now.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.